XML 43 R5.htm IDEA: XBRL DOCUMENT v3.20.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Millions
Total
Redeemable Noncontrolling Interest
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Balance, beginning of period at Dec. 30, 2018   $ 0.0        
Redeemable Noncontrolling Interest            
Net income (loss) $ 3.1         $ 3.1
Changes in noncontrolling interest   15.0        
Balance, end of period at Mar. 31, 2019   15.0        
Balance, beginning of period (in shares) at Dec. 30, 2018     103,800,000      
Balance, beginning of period at Dec. 30, 2018 519.3   $ 0.0 $ 1,244.5 $ (0.7) (724.5)
Increase (Decrease) in Stockholders' Equity            
Stock-based compensation 2.6     2.6    
Issuance of common stock for employee stock purchase plan, options and warrants (in shares)     200,000      
Issuance of common stock for employee stock purchase plan, options and warrants 1.7     1.7    
Restricted stock issued and related taxes (in shares)     100,000      
Restricted stock issued and related taxes (0.8)     (0.8)    
Issuance of common stock for acquisitions (in shares)     1,800,000      
Issuance of common stock for acquisitions 27.0     27.0    
Net income (loss) 3.1         3.1
Other comprehensive income, net of tax 0.0          
Balance, end of period (in shares) at Mar. 31, 2019     105,900,000      
Balance, end of period at Mar. 31, 2019 552.9   $ 0.0 1,275.0 (0.7) (721.4)
Balance, beginning of period at Dec. 29, 2019 15.0 15.0        
Redeemable Noncontrolling Interest            
Net income (loss) (0.2)         (0.2)
Balance, end of period at Mar. 29, 2020 $ 15.0 $ 15.0        
Balance, beginning of period (in shares) at Dec. 29, 2019 106,635,508   106,600,000      
Balance, beginning of period at Dec. 29, 2019 $ 574.1   $ 0.0 1,286.5 (0.4) (712.0)
Increase (Decrease) in Stockholders' Equity            
Stock-based compensation 4.7     4.7    
Issuance of common stock for employee stock purchase plan, options and warrants (in shares)     200,000      
Issuance of common stock for employee stock purchase plan, options and warrants 2.6     2.6    
Restricted stock issued and related taxes (in shares)     200,000      
Restricted stock issued and related taxes (1.2)     (1.2)    
Net income (loss) (0.2)         (0.2)
Other comprehensive income, net of tax $ 0.2       0.2  
Balance, end of period (in shares) at Mar. 29, 2020 106,960,828   107,000,000.0      
Balance, end of period at Mar. 29, 2020 $ 580.2   $ 0.0 $ 1,292.6 $ (0.2) $ (712.2)